We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Clinical islet cell transplantation - recent advances.
- Authors
Saravanan, Prathab Balaji; Loganathan, Gopalakrishnan; Naziruddin, Bashoo; Balamurugan, Appakalai N.
- Abstract
Type-1 diabetes mellitus (T1DM) caused by autoimmune destruction of insulin-producing beta-cells essentially requires treatment with exogenous insulin therapy. Despite the education, technology and improvements in insulin formulations, patients face the ongoing life-threatening hypoglycaemia with poor quality of life as well as progressive disease leading to microand macro-vascular complications of diabetes. Islet transplantation offers an alternative therapeutic option for these patients. In this review, we discuss the recent advancements in this field tracking from the history of pancreatic islet transplantation to the present-day challenges of clinical islet cell transplantation. We summarize the cutting-edge clinical research with special reference to the results of current trials, including Clinical Islet Transplant Consortium, improvements in immunosuppressive protocols, the need for beta-cell replacement therapies, including the application of induced pluripotent stem cells and mesenchymal stem cells.
- Subjects
TREATMENT of diabetes; TYPE 1 diabetes; ISLANDS of Langerhans transplantation; INSULIN therapy; QUALITY of life; IMMUNOSUPPRESSION; INDUCED pluripotent stem cells
- Publication
Current Science (00113891), 2017, Vol 113, Issue 7, p1267
- ISSN
0011-3891
- Publication type
Article
- DOI
10.18520/cs/v113/i07/1267-1276